BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 11794690)

  • 1. The end is just the beginning: megakaryocyte apoptosis and platelet release.
    Li J; Kuter DJ
    Int J Hematol; 2001 Dec; 74(4):365-74. PubMed ID: 11794690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
    Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
    Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cells.
    Sigurjónsson OE; Gudmundsson KO; Haraldsdóttir V; Rafnar T; Gudmundsson S
    J Hematother Stem Cell Res; 2002 Apr; 11(2):389-400. PubMed ID: 11983110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells.
    Nagata Y; Nagahisa H; Aida Y; Okutomi K; Nagasawa T; Todokoro K
    J Biol Chem; 1995 Aug; 270(34):19673-5. PubMed ID: 7649975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
    Cheng L; Qasba P; Vanguri P; Thiede MA
    J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
    Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
    Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells.
    Perdomo J; Yan F; Leung HHL; Chong BH
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin-induced CXC chemokines, NAP-2 and PF4, suppress polyploidization and proplatelet formation during megakaryocyte maturation.
    Oda M; Kurasawa Y; Todokoro K; Nagata Y
    Genes Cells; 2003 Jan; 8(1):9-15. PubMed ID: 12558795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoiesis: new concepts.
    van Geet C
    Verh K Acad Geneeskd Belg; 2004; 66(1):5-24; discussion 24-7. PubMed ID: 15074080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
    Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
    Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin derived from human embryonic kidney cells stimulates an increase in DNA content of murine megakaryocytes in vivo.
    McDonald TP; Jackson CW
    Exp Hematol; 1990 Aug; 18(7):758-63. PubMed ID: 2199205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro.
    Choi ES; Hokom M; Bartley T; Li YS; Ohashi H; Kato T; Nichol JL; Skrine J; Knudten A; Chen J
    Stem Cells; 1995 May; 13(3):317-22. PubMed ID: 7542117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation.
    Nagahisa H; Nagata Y; Ohnuki T; Osada M; Nagasawa T; Abe T; Todokoro K
    Blood; 1996 Feb; 87(4):1309-16. PubMed ID: 8608219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of megakaryocytopoiesis.
    Avraham H
    Stem Cells; 1993 Nov; 11(6):499-510. PubMed ID: 8111309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin: understanding and manipulating platelet production.
    Kaushansky K
    Annu Rev Med; 1997; 48():1-11. PubMed ID: 9046940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of megakaryocytopoiesis by thrombopoietin.
    McDonald TP
    Ann N Y Acad Sci; 1987; 509():1-24. PubMed ID: 3322129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors.
    Noetzli LJ; French SL; Machlus KR
    Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1288-1300. PubMed ID: 31043076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
    Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
    Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Mpl ligands on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB
    Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megakaryothrombopoiesis during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin.
    Woo SY; Kie JH; Ryu KH; Moon HS; Chung WS; Hwang DH; Kim SK; Han TH; Hahn MJ; Chong YH; Park HK; Seoh JY
    Scand J Immunol; 2002 Jan; 55(1):88-95. PubMed ID: 11841696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.